What Clearasil does

Clearasil is a US-based over-the-counter acne treatment brand that manufactures and distributes salicylic acid-based skincare products for consumers with acne-prone skin. The company, founded in 1950 and headquartered in Islandia, United States, operates as a brand under RB Health (US) LLC, which is itself a subsidiary of Reckitt, the UK-listed multinational consumer goods company. The product line is organized around two sub-brands — Rapid Rescue, a fast-acting formulation claiming visible results in as little as four hours and addressing five different acne types, and Stubborn Acne Control, a 5-in-1 daily treatment line. The core SKU set consists of medicated acne treatment pads (90-count) and exfoliating/deep-treatment face washes (6.78 fl oz) formulated for normal to oily skin.

The underlying technology is rooted in salicylic acid-based topical formulations marketed with performance claims around speed of action and multi-acne-type coverage, rather than in any proprietary digital or AI-enabled platform. The business model is a classic consumer goods hardware-sales model: Clearasil generates revenue through unit sales of its OTC products distributed via mass-market retail channels (leveraging parent Reckitt's distribution infrastructure) and supplemented by a direct-to-consumer e-commerce storefront at clearasil.us. Go-to-market combines this omnichannel distribution with top-of-funnel organic marketing across Instagram, Facebook, Twitter, YouTube, and an educational skincare blog targeting teenagers and young adults seeking accessible acne treatment.

Pricing is not publicly disclosed on the brand's US website, consistent with standard OTC shelf-pricing dynamics set by retail partners rather than the brand. The target customer is a horizontal persona — individuals dealing with pimples, stubborn acne, and clogged pores — with no evidence of enterprise or B2B customers. Customer inquiries are routed through Reckitt's corporate consumer engagement function ([email protected], 866-252-5327), underscoring the brand's structural integration with its parent and the absence of standalone operating infrastructure.

Name

Clearasil

Legal name

RB Health (US) LLC

Website

https://clearasil.com

Company type

Private

Founded year

1950

Operating status

Operating

Short description

Clearasil is a US OTC acne treatment brand, owned by RB Health (US) LLC under Reckitt, that sells salicylic acid-based acne pads and face washes under the Rapid Rescue and Stubborn Acne Control lines to consumers with acne-prone skin via retail and direct e-commerce.

Ownership category

akta.pro rank

Product category

OTC Acne Treatment Skincare

NAICS

Soap, Cleaning Compound, and Toilet Preparation Manufacturing (3256), Soap and Cleaning Compound Manufacturing (32561)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844), Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (2840)

akta.pro primary industry

Treatment Skincare (Serums, Actives, Acne & Anti-aging) (CRABAAAB)

akta.pro secondary industry

Body Scrubs & Exfoliating Cleansers (CRABAEAD)

Keywords

• Acne treatment products
• Medicated skincare
• OTC dermatology
• Facial cleansers
• Acne care pads

Headquarters

HQ city

Islandia

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Marketing or Sales, Personnel, Operations

Revenue model

1. Consumer Health Product Sales: Clearasil generates revenue through the sale of over-the-counter acne treatment products including medicated pads and face washes. Products are sold directly to consumers via e-commerce and through retail distribution channels.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Clearasil manufactures and sells over-the-counter acne treatment products based on salicylic acid formulations. The product line includes medicated acne treatment pads and exfoliating face washes organized into two solution lines—Rapid Rescue (for pimples that won't go away, delivering visible results in as little as four hours) and Stubborn Acne Control (a 5-in-1 daily treatment for ongoing acne management).

Product overview

Clearasil is a medicated acne care brand offering a product line centered on salicylic acid-based treatments. The portfolio consists of two main solution lines: Rapid Rescue (for pimples that won't go away, targeting five different types of acne with fast-acting formulas) and Stubborn Acne Control (for ongoing acne management with 5-in-1 daily treatment pads). Products include acne treatment pads (available in both Rapid Rescue deep treatment and Stubborn Acne 5-in-1 daily formulations) and acne face washes (exfoliating and daily treatment washes for normal to oily skin). All products are positioned as medicated skincare that cares for the skin while treating acne.

Differentiator

Problem solved

Functional benefit

Brands

• Rapid Rescue: Acne treatment line for pimples that won't go away, fights five different types of acne for clearer skin fast
• Stubborn Acne Control

Products and services

• Clearasil Salicylic Acid Stubborn Acne Control Pads, 90 count Salicylic acid acne treatment pads designed for stubborn acne control, providing a 5-in-1 daily treatment approach for consumers with persistent acne.
• Clearasil Salicylic Acid Rapid Rescue Deep Treatment Acne Pads, 90 count Deep treatment acne pads that deliver pore cleansing treatment with visible results in as little as four hours for rapid acne rescue.
• Clearasil Stubborn Acne Exfoliating Face Wash, Normal to Oily Skin, 6.78 fl oz Exfoliating face wash designed for normal to oily skin that fights five different acne problems as part of the Stubborn Acne Control line.
• Clearasil Rapid Rescue Deep Treatment Wash, Normal to Oily Skin, 6.78 fl oz Daily face wash for normal to oily skin that provides deep cleansing treatment for rapid acne rescue as part of the Rapid Rescue line.

Quantifiable outcome

• Visible results in as little as four hours

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators1 record

Recent moves4 records

Expansion highlights3 records

Direct peers

• Differin: Galderma-owned OTC acne treatment brand featuring adapalene gel, directly competing in the same OTC acne shelf space as Clearasil. Targets the same acne-prone consumer with a once-daily retinoid regimen, often cross-shopped with Clearasil at retail.
• The Ordinary: Deciem-owned active-ingredient skincare brand with popular salicylic acid and AHA/BHA acne solutions. Competes for ingredient-savvy younger consumers who might otherwise buy Clearasil, with a transparent pricing and ingredient-forward value proposition.
• CeraVe: La Roche-Posay (L'Oréal)-owned skincare brand with strong dermatologist endorsement and a growing acne treatment line including salicylic acid cleansers. Competes with Clearasil in mass and drug channel but at a slightly premium positioning with a broader skincare regimen.
• Murad: Clinical skincare brand with a dedicated acne treatment line (e.g., Acne Control), positioned at a premium tier with dermatologist associations. Comparable to Clearasil in acne-focused regimen but with a higher price point and spa-channel heritage.
• Proactiv: Direct-to-consumer and retail acne treatment brand built on benzoyl peroxide regimen kits. Competes for the same acne-prone consumer with a subscription and multi-step model, overlapping significantly with Clearasil's Rapid Rescue and Stubborn Acne lines.
• Neutrogena: Johnson & Johnson-owned mass-market skincare brand with a deep acne treatment portfolio including salicylic acid pads and washes. Direct competitor to Clearasil in OTC acne at similar price points across the same drugstore and mass retail channels.
• Mario Badescu: Heritage acne and skincare brand with salicylic acid-based acne treatment products and a clear acne-prone consumer focus. Closely comparable product line and price tier to Clearasil, with significant overlap in drugstore and DTC channels.
• La Roche-Posay: L'Oréal-owned dermocosmetics brand with a dedicated Effaclar line for acne-prone skin. Closely comparable to Clearasil in active ingredients (salicylic acid, niacinamide) and acne focus, but positioned at a premium tier with dermatologist channel distribution.

Emerging players

• Curology: Teledermatology and personalized prescription skincare brand offering custom-formulated acne treatments. Competes with Clearasil for the same consumer but via a subscription telehealth model with prescription actives, representing the digital-native threat to traditional OTC acne brands.

Broad incumbents

• Johnson & Johnson Consumer Health: Parent of Neutrogena and Aveeno, J&J Consumer Health is a broad incumbent in OTC skincare and acne treatment. Comparable to Reckitt as a conglomerate parent housing multiple mass-market skincare brands that compete for the same acne-prone consumer spending.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key highlights6 records

Customer concentration

• Xx.com/clearasil
• YouTubeyoutube.com/user/clearasil
• Facebookfacebook.com/ClearasilUS
• Instagraminstagram.com/clearasil

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clearasil